• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hosp Pediatr . COVID-19 in Pediatrics: Characteristics of Hospitalized Children in New Jersey

tetano

Editor, Senior Moderator
Hosp Pediatr


. 2021 Jan;11(1):79-87.
doi: 10.1542/hpeds.2020-001719.
COVID-19 in Pediatrics: Characteristics of Hospitalized Children in New Jersey


Sejal M Bhavsar[SUP] 1 2 [/SUP], Katharine N Clouser[SUP] 3 2 [/SUP], Jasmine Gadhavi[SUP] 3 [/SUP], Okechukwu Anene[SUP] 2 4 [/SUP], Ranbir Kaur[SUP] 2 4 [/SUP], Rachel Lewis[SUP] 3 2 [/SUP], Srividya Naganathan[SUP] 2 5 [/SUP], Zuzanna Michalak[SUP] 3 [/SUP], Clara Q Chen[SUP] 2 [/SUP], Pooja Shah[SUP] 3 6 [/SUP], Anita Siu[SUP] 5 6 [/SUP], Cathleen Ballance[SUP] 2 5 [/SUP]



Affiliations

Abstract

Objectives: Understanding the risk factors, predictors, and clinical presentation of coronavirus disease 2019 (COVID-19) in pediatric patients with severe disease.
Methods: We conducted a retrospective chart review of pediatric patients admitted between March 1, 2020, and May 31, 2020, to a large health network in New Jersey with positive test results for severe acute respiratory syndrome coronavirus 2 on reverse transcriptase polymerase chain reaction, rapid testing, or serum immunoglobulin G testing; we included demographic characteristics, clinical features, and outcomes.
Results: A total of 81 patients ≤21 years old were admitted with positive test results for severe acute respiratory syndrome coronavirus 2 on reverse transcriptase polymerase chain reaction and/or serum immunoglobulin testing. Sixty-seven patients (82.7%) were admitted for management of acute COVID-19 infection, whereas 14 (17.3%) were admitted for management of multisystem inflammatory syndrome in children (MIS-C). Of the 81 hospitalized patients, 28 (34.6%) required intensive care. A majority of patients (42 [51.9%]) admitted for both acute COVID-19 infection and MIS-C were Hispanic. Underlying chronic health conditions were not present in most patients. Obesity (mean BMI of 41.1) was noted in the patients with MIS-C requiring ICU care, although not statistically significant. Absolute lymphopenia and elevated levels of inflammatory markers were statistically significant in the patients with MIS-C treated in the ICU.
Conclusions: This study adds to the growing literature of potential risk factors for severe disease in pediatric patients due to COVID-19 infection and MIS-C. Patients of Hispanic ethnicity represented the majority of patients with both acute COVID-19 infection and MIS-C, despite only representing 10% to 20% of the population our hospitals serve. Infants and patients with chronic health conditions were not at increased risk for severe disease. Absolute lymphopenia and elevated levels of inflammatory markers were associated with more severe disease.
 
Back
Top Bottom